A Phase 1 Study of ASP5834 in Participants With Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies With KRAS Mutations or KRAS Amplifications
NCT07094204 · RECRUITING · Phase 1
We track 2 ClinicalTrials.gov studies led by Astellas Pharma Inc. The portfolio skews toward Phase 1 (1 trials).
2 clinical trials sponsored by Astellas Pharma Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 50% |
| N/A | 1 | 50% |
Astellas Pharma Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 1, N/A.
Astellas Pharma Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Astellas Pharma Inc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.